Arcus Biosciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 02/12/2026 | 31.42 M | $748.85 M | 0.00% | 29.51% |
| BLACKROCK, INC. | 02/12/2026 | 15.00 M | $357.40 M | 26.98% | 14.08% |
| VANGUARD GROUP INC | 01/29/2026 | 7.96 M | $189.76 M | 20.11% | 7.48% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 5.19 M | $123.65 M | 40.66% | 4.87% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 5.18 M | $123.55 M | 309.43% | 4.87% |
| STATE STREET CORP | 02/13/2026 | 4.58 M | $109.07 M | 34.82% | 4.30% |
| WOODLINE PARTNERS LP | 02/17/2026 | 3.77 M | $89.83 M | 0.00% | 3.54% |
| MARSHALL WACE, LLP | 02/13/2026 | 3.39 M | $80.73 M | 100.00% | 3.18% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 3.28 M | $78.16 M | -24.29% | 3.08% |
| SIREN, L.L.C. | 02/13/2026 | 3.01 M | $71.66 M | 3.26% | 2.82% |
| FISHER ASSET MANAGEMENT, LLC | 02/09/2026 | 1.95 M | $46.46 M | 167.40% | 1.83% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.91 M | $45.46 M | 19.33% | 1.79% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 1.69 M | $40.21 M | 18.83% | 1.58% |
| SAMLYN CAPITAL, LLC | 02/17/2026 | 1.60 M | $38.23 M | 100.00% | 1.51% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.52 M | $36.32 M | 1.44% | 1.43% |
| TORONTO DOMINION BANK | 02/17/2026 | 1.48 M | $35.38 M | 100.00% | 1.39% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 1.23 M | $29.37 M | -30.47% | 1.16% |
| MORGAN STANLEY | 02/13/2026 | 1.21 M | $28.85 M | -21.18% | 1.14% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.17 M | $27.84 M | 22.92% | 1.10% |
| FMR LLC | 02/17/2026 | 1.14 M | $27.05 M | -50.56% | 1.07% |
| BARCLAYS PLC | 02/13/2026 | 1.11 M | $26.51 M | 528.11% | 1.04% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 1.10 M | $26.13 M | -10.27% | 1.03% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 1.08 M | $25.74 M | 100.00% | 1.01% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 1.05 M | $25.02 M | 100.00% | 0.99% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.00 M | $23.85 M | -26.45% | 0.94% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 968.60 K | $23.08 M | 48.40% | 0.91% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 968.24 K | $23.07 M | 11.15% | 0.91% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 929.98 K | $22.16 M | -16.97% | 0.87% |
| 02/17/2026 | 916.31 K | $21.84 M | 100.00% | 0.86% | |
| FRANKLIN RESOURCES INC | 02/11/2026 | 853.49 K | $20.34 M | 100.00% | 0.80% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 815.56 K | $19.43 M | 712.53% | 0.77% |
| NORTHERN TRUST CORP | 02/17/2026 | 794.80 K | $18.94 M | 12.29% | 0.75% |
| CANDRIAM S.C.A. | 04/30/2026 | 790.61 K | $18.84 M | 108.91% | 0.74% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 767.70 K | $18.29 M | 100.00% | 0.72% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 711.98 K | $16.97 M | 100.00% | 0.67% |
| FIRST TURN MANAGEMENT, LLC | 02/13/2026 | 565.14 K | $13.47 M | 100.00% | 0.53% |
| DECHENG CAPITAL LLC | 02/12/2026 | 541.56 K | $12.91 M | -1.10% | 0.51% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 504.46 K | $12.02 M | 7.28% | 0.47% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/17/2026 | 431.33 K | $10.28 M | -31.28% | 0.41% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 424.07 K | $10.11 M | 404.71% | 0.40% |
| INVESCO LTD. | 02/19/2026 | 414.37 K | $9.87 M | 41.71% | 0.39% |
| UBS GROUP AG | 01/29/2026 | 411.26 K | $9.80 M | 145.67% | 0.39% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 407.51 K | $9.71 M | 21.82% | 0.38% |
| PDT PARTNERS, LLC | 02/17/2026 | 388.34 K | $9.25 M | 0.00% | 0.36% |
| ABRDN PLC | 01/16/2026 | 384.60 K | $9.17 M | 15.96% | 0.36% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 379.10 K | $9.03 M | 100.00% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 341.87 K | $8.15 M | -12.15% | 0.32% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 300.00 K | $7.15 M | 100.00% | 0.28% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/13/2026 | 295.43 K | $7.04 M | 9.47% | 0.28% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 270.00 K | $6.43 M | 100.00% | 0.25% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arcus Biosciences Inc institutional Ownership - FAQ's
During the previous two years, 275 institutional investors and hedge funds held shares of Arcus Biosciences Inc. The most heavily invested institutionals were:
Fisher Asset Management, LLC: 2.19 M
Candriam S.C.A.: 790,613
abrdn plc: 769,787
Bank of New York Mellon Corp: 511,166
PRINCIPAL FINANCIAL GROUP INC: 413,778
UBS Group AG: 288,857
114.01% of Arcus Biosciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 140.26 M shares in the last 24 months. This purchase volume represents approximately $3.29 B in transactions.